The company
Natural Alternatives International, Inc.
NAII · Nasdaq
NAII stood above a rising 150-day average in 9 of the last 52 weekly readings, and has been out of that trend for the last 36 weeks. It is 46.4% below that average now. Pharmaceuticals: 37% of its 74 stocks in an uptrend (−1 points in four weeks); Health Care: 27% (−6 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 36
- Industry in uptrend
- 37% -1 in 4 wk
- Insider buys, 12 months
- $54K
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 23 (+2)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 9 of 52 weeks.
Pharmaceuticals: A minority of its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Mark A. LedouxCEO/Chairman | bought | 532at $2.80 | 6 Mar 2026filed 6 Mar 2026 |
| Mark A. LedouxCEO/Chairman | bought | 218at $2.75 | 5 Mar 2026filed 6 Mar 2026 |
| Mark A. LedouxCEO/Chairman | bought | 500at $2.77 | 4 Mar 2026filed 6 Mar 2026 |
| Mark A. LedouxCEO/Chairman | bought | 500at $2.79 | 2 Mar 2026filed 3 Mar 2026 |
| Mark A. LedouxCEO/Chairman | bought | 250at $2.80 | 27 Feb 2026filed 27 Feb 2026 |
| Mark A. LedouxCEO/Chairman | bought | 500at $2.85 | 27 Feb 2026filed 3 Mar 2026 |
| Mark A. LedouxCEO/Chairman | bought | 500at $2.85 | 26 Feb 2026filed 27 Feb 2026 |
| Mark A. LedouxCEO/Chairman | bought | 500at $2.81 | 25 Feb 2026filed 27 Feb 2026 |
| Mark A. LedouxCEO/Chairman | bought | 1,000at $2.71 | 24 Feb 2026filed 24 Feb 2026 |
| Mark A. LedouxCEO/Chairman | bought | 750at $2.70 | 23 Feb 2026filed 24 Feb 2026 |
| Mark A. LedouxCEO/Chairman | bought | 250at $2.66 | 20 Feb 2026filed 24 Feb 2026 |
| Mark A. LedouxCEO/Chairman | bought | 1,500at $2.56 | 19 Feb 2026filed 20 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| CALDWELL SUTTER CAPITAL, INC.reduced · filed 5 Aug 2026 | 498,220$1.2M | -572−0.1% |
| DIMENSIONAL FUND ADVISORS LPreduced · filed 11 Aug 2026 | 335,789$803K | -18,950−5.3% |
| MORGAN STANLEYadded · filed 13 Aug 2026 | 307,630$735K | +39,380+14.7% |
| Mink Brook Asset Management LLCreduced · filed 14 Aug 2026 | 293,447$701K | -262−0.1% |
| RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026 | 277,457$663K | -13,899−4.8% |
| VANGUARD CAPITAL MANAGEMENT LLCunchanged · filed 13 Aug 2026 | 210,880$504K | 00.0% |
| Integrated Wealth Concepts LLCadded · filed 12 Aug 2026 | 88,186$211K | +76,186+634.9% |
| CITADEL ADVISORS LLCadded · filed 14 Aug 2026 | 75,746$181K | +32,038+73.3% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLCreduced · filed 14 Aug 2026 | 61,495$147K | -13,821−18.4% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 43,711$105K | -8,694−16.6% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.